Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huangkui Capsule for chronic kidney disease
ChiCTR-TRC-10000923Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chronic kidney disease (CKD) and primary glomerulonephritis comparing Huangkui Capsule, Losartan and Huangkui Capsule + losartan (3 arms). Primary endpoint: 24-hour urinary protein excretion. Started Jun 2010; status: completed.
02
Drugs
huang kui capsulelosartan
03
Conditions
chronic kidney disease (CKD)primary glomerulonephritis
Beyond the preview
Go deeper on ChiCTR-TRC-10000923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000923.